Pune, India -- (SBWIRE) -- 09/05/2018 -- Market Highlights:
Bone biopsy is a procedure in which a sample of bone tissue is taken and observed under the microscope to diagnose various bone disorders such as osteopenia. It is of two types namely, needle biopsy and open biopsy. In needle biopsy, a biopsy needle is used to take the tissue sample. In open biopsy, an incision is made through the skin and the sample is taken. Bone cancer, bone infection or inflammation, chronic kidney disease and osteoporosis are major indications for bone biopsy.
Rising prevalence of cancer and increasing demand for new diagnostic procedures are the major factors driving the growth of the market across the globe. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Splendid research in the field of oncology also boost the market. However, low patient awareness about chronic kidney disease and importance of early diagnosis among the people may restrain the market growth.
According to the World Health Organisation (WHO), cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to the Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking.
The Global Bone Biopsy Market is expected to grow at a CAGR of 5.7% during the forecast period.
Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5341
Regional Analysis:
America holds the first position in the bone biopsy market owing to the rising prevalence of cancer in the U.S. and increasing demand for new cancer diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare diagnostic industry. The prevalence of osteoporosis is found to be higher in the population over 35 years for age. Changing lifestyle, emphasis on fitness and exercise, and overall development of medical device industry also accelerate the growth of the market.
Europe is the second largest market for bone biopsy. In Europe, there is an increasing demand for advanced bone biopsy devices, and extensive research and development activities by clinical research and academic institutes for cancer diagnosis and treatment. Germany is the largest market followed by France. The market in Germany is driven by increasing demand for specialty care services.
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as kidney disease, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand of technologically advanced medical devices in diagnostic centers and availability of highly qualified medical professional dedicated to research in oncology. Additionally, rising healthcare expenditure and extensive growth of medical device industry also influence the use of medical devices for diagnosis of various diseases such as osteoporosis, diabetes, cancer, and others.
The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about cancer treatment. In the Middle East & Africa, United Arab Emirates captures the largest market share for bone biopsy owing to the availability of better healthcare infrastructure and a wide scope for research. In Africa, the market also shows a positive growth owing to development of healthcare system in African countries, and increasing demand for primary care services.
Key players of Global Bone Biopsy Market:
- C R Bard (U.S.)
- Becton, Dickinson and Company (U.S.)
- B. Braun Melsungen AG
- Hologic, Inc. (U.S.)
- Cook Medical (U.S.)
- Devicor Medical Products Inc. (U.S.)
- Argon Medical Inc. (U.S.) and others.
Intended Audience:
- Medical Device Manufacturers
- Medical Device Suppliers
- Medical Research Laboratories
- Healthcare IT Companies
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Segments:
The global bone biopsy market is segmented on the basis of type, indication and end user.
On the basis of the component, market is segmented into needle biopsy and open biopsy.
On the basis of the application, the market is segmented into bone cancer, bone infection, chronic kidney disease, osteoporosis, and others
On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, diagnostic centers, and others.
Avail Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/5341
BRIEF TOC:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
…TOC CONTINUED
Have a Question Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5341
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.